Elan Pharmaceuticals, Inc.
225Patents
63Active
225Granted
45Portfolio score
Filing activity: Mar 12, 1992 → Sep 18, 2012 · 60 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5942400A | Assays for detecting .beta.-secretase | Emerging Cross-Sectional Technologies | 130 | Expired |
| US6114133A | Methods for aiding in the diagnosis of Alzheimer's disease by measuring amyloid-.beta. peptide (x-.gtoreq.41) | Emerging Cross-Sectional Technologies | 112 | Expired |
| US6284221A | Method for identifying .beta.-amyloid peptide production inhibitors | Emerging Cross-Sectional Technologies | 90 | Expired |
| US6033665A | Compositions and methods for modulating leukocyte adhesion to brain endothelial cells | Chemistry; Metallurgy | 74 | Expired |
| US7049306B2 | Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4. | Emerging Cross-Sectional Technologies | 70 | Expired |
| US7524812B2 | Pharmaceutical formulation comprising ziconotide | Chemistry; Metallurgy | 64 | Active |
| US6054429A | Epidural method of producing analgesia | Human Necessities | 61 | Expired |
| US6596305B1 | Method of controlling the size of liposomes | Emerging Cross-Sectional Technologies | 60 | Expired |
| US6221645A | .beta.-secretase antibody | Chemistry; Metallurgy | 59 | Expired |
| US7176242B2 | N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives | Chemistry; Metallurgy | 56 | Expired |
| US5891849A | Methods and formulations for preventing progression of neuropathic pain | Human Necessities | 55 | Expired |
| US8349321B2 | Immunoglobulin formulation and method of preparation thereof | Chemistry; Metallurgy | 54 | Active |
| US8246958B2 | Methods of inhibiting alpha-4-dependent interactions with VCAM-1 with anti-VLA-4 antibodies | Physics | 53 | Active |
| US6509331B1 | Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds | Chemistry; Metallurgy | 47 | Expired |
| US6245964A | Transgenic rodent comprising APP-Swedish | Physics | 44 | Expired |
| US6287793A | Diagnostic methods for alzheimer's disease | Emerging Cross-Sectional Technologies | 44 | Expired |
| US7268109B2 | Method for reducing pain | Chemistry; Metallurgy | 41 | Expired |
| US6018024A | Methods and compositions for monitoring cellular processing of beta-amyloid precursor protein | Emerging Cross-Sectional Technologies | 37 | Expired |
| US6329163A | Assays for detecting .beta.-secretase inhibition | Chemistry; Metallurgy | 36 | Expired |
| US7919088B2 | Treatment and delay of onset of synucleinopathic and amyloidogenic disease | Chemistry; Metallurgy | 34 | Active |
| US7910333B2 | Antibodies to alpha-synuclein | Emerging Cross-Sectional Technologies | 33 | Active |
| US6407128B1 | Method for increasing the bioavailability of metaxalone | Human Necessities | 33 | Expired |
| US7358331B2 | Truncated fragments of alpha-synuclein in Lewy body disease | Physics | 32 | Expired |
| US6191166A | Methods and compounds for inhibiting .beta.-amyloid peptide release and/or its synthesis | Chemistry; Metallurgy | 32 | Expired |
| US6407066B1 | Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4 | Human Necessities | 30 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.